Job title: Vice President - Development
Ying Buechler re-joined Ambrx in August 2018 as Vice President of Development. As the CMC leader, she is responsible for strategy and execution of protein therapeutics development and manufacturing. Previously, she was Executive Director of Biologics Development and Manufacturing at aTyr Pharma, where she led the team comprising upstream and downstream process development, analytical and formulation development functions for more than 7 years, successfully executed development and manufacturing activities for multiple clinical programs. Ying was with Ambrx for the prior 7 years and served as director of process development and characterization, where she led process and analytical/formulation development functions, and led interactions with contract manufacturing organizations. She was the project leader of Ambrx’s 1st program, successfully led the efforts of developing Ambrx’s 1st clinical product while maturing the new technology. She has over 25 years of biotech industrial experience on therapeutic protein development and manufacturing. Ying received her Ph.D. in Chemistry from University of California, San Diego, and her BS from Peking University in Beijing, China.